Meet One-on-One with...OrbiMed -Confirmation

Sep 23 2015https://www.eventbrite.com/e/meet-one-on-one-withorbimed-confirmation-tickets-18...

JLABS BAY AREA EVENT Congratulations! You have been approved to attend a one-on-one meeting with OrbiMed. To secure your time slot please register your team who will be in attendance. After receiving confirmation of your registration you will be notified of your meeting time slot. 

Note: Two registrations are required in order to attend the presentation & lunch, and the one-on-one meeting. After registering here for your one-on-one meeting, and if you have not done so yet, please register at https://jlabsbay-orbimed2015.eventbrite.com
. 

OrbiMed is the world's largest life sciences-dedicated investor with specific interests in biopharma, diagnostics, med tech and healthcare services. They’ve helped to nurture and commercialize some of today's most successful healthcare companies focused on creating healthier, longer and more productive lives around the globe. OrbiMed is seeking novel healthcare innovations across biopharma, devices, diagnostics and healthcare IT at any stage of development in both public and private companies. 

Agenda:
10:30am | Registration Opens and Networking
11:00am | Presentation and Q&A 
12:00pm | Networking Lunch 
12:30-5:00pm | One-on-one Meetings* 
*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ended on September 11th.

Peter ThompsonOrbiMed Participating Representative:
Peter Thompson, M.D. | Private Equity Partner, OrbiMed 
Peter Thompson is currently a Private Equity Partner with OrbiMed who brings over 20 years of industry experience. He co-founded and was CEO of Trubion Pharmaceuticals, co-founded Cleave BioSciences, serves on the Boards of Cleave, Anthera, Methylgene, Principia Biopharma, and Response Biomedical, and was an executive of Chiron Corporation and Becton Dickinson. Dr. Thompson is an Ernst & Young Entrepreneur of the Year awardee, an Affiliate Professor of Neurosurgery at the University of Washington, an inventor on numerous patents, and a board-certified internist and oncologist. He was on staff at the National Cancer Institute following his internal medicine training at Yale University. 
Connect with Peter: Connect on LinkedIn 

Fees: 
Presentation & Lunch
$25 | General Public
$35 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until October 13th (or sold out). 

One-on-One Meeting
FREE | Application
FREE | Accepted Companies 
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period ends on September 11th. Your application will be reviewed and you will be notified of acceptance by September 25, 2015. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved. 

Venue:
Johnson & Johnson Innovation, JLABS
329 Oyster Point Blvd - 3rd Floor
South San Francisco, California 

About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, NCI, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCATS, NINDS, Johnson & Johnson Innovation, Poliwogg, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.

 

Share